Frontiers in Cardiovascular Medicine

Case Report

Published on 16 Jan 2026

Case Report: Immune checkpoint inhibitor-associated pulmonary hypertension

in Cardio-Oncology

Shanshan Yuan
Xueqing Hu
Yunquan Zhao
Hongyan Dai

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1705102

363 views

Original Research

Published on 15 Jan 2026

A case series and literature review of immune checkpoint inhibitors-associated myocarditis (ICIM) in non-small cell lung cancer

in Cardio-Oncology

Yongzhen Sun
Yuan Liu
Yan Wang
Xiaomin Dai
Lin Shi
Jing Bi
Jing Zhang
Yuanlin Song
Jinjun Jiang
Shujing Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1615085

292 views

Case Report

Accepted on 12 Jan 2026

Highly Suspected Fulminant Myocarditis Induced by the Immune Checkpoint Inhibitor Tislelizumab: A Case Report with Third-Degree Atrioventricular Block and Recurrent Ventricular Tachycardia

in Cardio-Oncology

Junru Qu
Miao Liu
Neil Johnson
Wenwen Zhang
Zhiqiang Wang
Yingying Su
beibei Du
Yuquan He

Frontiers in Cardiovascular Medicine

Review

Published on 08 Jan 2026

Cancer therapy-related cardiovascular aging: mechanisms, monitoring, and intervention strategies

in Cardio-Oncology

Xinyue Lin
Zhebin Wu
Yanfang Liu
Xiang Liao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1668623

489 views

Case Report

Published on 08 Jan 2026

Case Report: A case of heart failure recovery after non-ischemic cardiomyopathy following chimeric antigen receptor T-cell therapy

in Cardio-Oncology

G. Spears
J. C. Henson
S. Vellanki
A. Trikannad
H. Paydak

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1608404

404 views

Original Research

Published on 06 Jan 2026

Machine learning models using multimodal data accurately predict chemotherapy-induced cardiotoxicity in breast cancer

in Cardio-Oncology

Kundi Chen
Yuqiong An
Zhen Wang
Fang Nie

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1707889

592 views

Brief Research Report

Accepted on 05 Jan 2026

Undetectable Brain Natriuretic Peptide as a Marker of Ultrasound-Detected Hypovolemia in Patients with Cancer on Active Treatment

in Cardio-Oncology

Amy Tu Trinh Le
Raed Qarajeh
Bart Wilder
Akash Sharma
Lolita Golemi
Tochi Margaret Okwuosa

Frontiers in Cardiovascular Medicine

202 views

Clinical Trial

Published on 02 Jan 2026

Anthracycline-induced cardiotoxicity associated with myocardial energy metabolism: mechanisms revealed through an integration of 18F-FDG PET/CT and data-independent acquisition proteomics

in Cardio-Oncology

Yining Xu
Yihan Chen
Shujie Zhang
Biyun Zhang
Yao Zhu
Haiwen Ni
Weimin Jiang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1726943

443 views

Case Report

Published on 18 Dec 2025

Cardiac metastasis mimicking acute myocardial infarction in a patient with urachal carcinoma: a case report and diagnostic dilemma

in Cardio-Oncology

Huanglie Xie
Ke Zhang
Pengyu Hang
Chaoyang Zheng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1672655

764 views

Study Protocol

Published on 24 Nov 2025

Investigation of Sheng Mai Yin in the treatment of anthracycline-induced frequent premature ventricular contractions in cancer patients: study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial

in Cardio-Oncology

Qiwen Yang
Chaofeng Niu
Meng Li
Tangshun Wang
Ce Wang
Longzhen Han
Lan Wei
Yayue Zhang
Dong Li
Shuhua Yi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1670053

929 views

Review

Published on 14 Nov 2025

NO/NOS system dysregulation as a key molecular mechanism in chemotherapy-induced cardiotoxicity: a review

in Cardio-Oncology

András Nagy
Zoltán Virág
Viktória Kiss
Denise Börzsei
Csaba Varga
Renáta Szabó

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1682471

1,273 views

Systematic Review

Published on 11 Nov 2025

Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysis

in Cardio-Oncology

Luca Fazzini
Simone Angius
Nicola Campana
Luca Pascalis
Martino Deidda
Giordano Maria Pugliesi
Vincenzo Quagliariello
Nicola Maurea
Carlo Gabriele Tocchetti
Pietro Ameri

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1624023

931 views

Case Report

Published on 04 Nov 2025

Case Report: Diagnostic challenges and therapeutic approaches in cardiac intimal sarcoma: a rare clinical case study

in Cardio-Oncology

Chao Ma
Junyi Tang
Yin Xiao
Wenbin Tian
Tao Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1668911

887 views

Review

Published on 23 Oct 2025

Current strategies for prevention of cancer therapy-related cardiotoxicity: pharmacological, non-pharmacological and emerging approaches

in Cardio-Oncology

Michele Migliari
Luca Fazzini
Nicola Campana
Martino Deidda
Mariele Dessì
Christian Cadeddu Dessalvi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1668308

2,896 views

Original Research

Published on 10 Oct 2025

Analysis of risk factors for major adverse cardiac events in patients with multiple myeloma

in Cardio-Oncology

Yu Feng
Jingjing Zhou
Shilv Chen
Shuo Li
Tianlan Li
Yan Gao
Qianqian Wang
Yujie Xu
Chunxia Mao
Shanshan Liu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1633543

1,687 views

Systematic Review

Published on 22 Sep 2025

From bench to bedside: investigating SGLT2 inhibitors as a novel strategy against chemotherapy-induced cardiomyopathy

in Cardio-Oncology

Rade Jibawi Rivera
Faris Muaref
Sulaiman Paika
Abdullah Ruyyashi
Christopher S Gondi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1647747

2,623 views

Case Report

Published on 18 Sep 2025

A case report of hepatocarcinoma-originated pericardial malignancy

in Cardio-Oncology

Bin Wu
Zhixiao Wang
Weizhe Lin
Jian Xiong
Chaoyong He

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1643805

1,551 views
1 citation

Original Research

Published on 15 Sep 2025

L-shaped association of low-density lipoprotein cholesterol with all-cause and cardiovascular mortality in cancer survivors: a population-based cohort study

in Cardio-Oncology

Bowen Hou
Yali Hu
Hairong Wang
Huang Zhang
Xingyu Gao
Ying Cui
Yilin Zhao
Jing Xie
Xiaomei Yu
Lang Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1593824

2,520 views

Original Research

Published on 12 Sep 2025

SGLT2i use is associated with reduced risks of cardiopulmonary inflammatory complications in cancer patients with diabetes: a retrospective cohort study

in Cardio-Oncology

Dan Li
Yanlin Li
Lingyu Meng
Xin Yu
Min Jiao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1657240

1,440 views

Case Report

Published on 09 Sep 2025

Case Report: Coronary vasospasm precipitating STEMI and polymorphic ventricular tachycardia—a case of cardiotoxicity from 5-FU based chemotherapy in a 41-year-old woman

in Cardio-Oncology

Ammar Hasnie
Zachary Neace
Kristin Ellison
Aaron Hesselson
Karam Ayoub
Mohammed Al-Yafi
Amit Arbune

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1594338

1,628 views
1 citation

Systematic Review

Published on 03 Sep 2025

Pharmacological interventions to prevent cardiotoxicity in patients undergoing anthracycline-based chemotherapy: a network meta-analysis

in Cardio-Oncology

Xiaoyu Liu
Ran Ding
Aihua Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1612060

2,302 views

Case Report

Published on 25 Aug 2025

Case Report: The carney complex led to the tragic passing of a young girl in the prime of her life

in Cardio-Oncology

Shurong Yun
Xingquan Liu
Yaxi Wang
Zhiping Liu
Jing Wu
Shasha Duan
Xiaoshan Zhang
Yilu Shi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1603557

1,326 views

Mini Review

Published on 22 Aug 2025

MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances

in Cardio-Oncology

Hongyun Mao
Jing Hu
Chenshuo Yu
Sicong Xie
Cheng Chang
Juanjuan Peng
Yang Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1614878

2,468 views
1 citation

Case Report

Published on 15 Aug 2025

Case Report: Case of cardiac metastases from melanoma, treated by stereotactic radiotherapy, using a MICRA implant

in Cardio-Oncology

Mehdi Belbachir
Nicolas Danthez
David Rotzinger
Antiochos Panagiotis
Etienne Pruvot
Veronique Vallet
Maude Gondre
Gregoire Berthod
Sofia Latifyan
Rita Demicheli

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1588106

2,200 views

388 articles

articles

Case Report: Immune checkpoint inhibitor-associated pulmonary hypertension

A case series and literature review of immune checkpoint inhibitors-associated myocarditis (ICIM) in non-small cell lung cancer

Highly Suspected Fulminant Myocarditis Induced by the Immune Checkpoint Inhibitor Tislelizumab: A Case Report with Third-Degree Atrioventricular Block and Recurrent Ventricular Tachycardia

Cancer therapy-related cardiovascular aging: mechanisms, monitoring, and intervention strategies

Case Report: A case of heart failure recovery after non-ischemic cardiomyopathy following chimeric antigen receptor T-cell therapy

Machine learning models using multimodal data accurately predict chemotherapy-induced cardiotoxicity in breast cancer

Undetectable Brain Natriuretic Peptide as a Marker of Ultrasound-Detected Hypovolemia in Patients with Cancer on Active Treatment

Anthracycline-induced cardiotoxicity associated with myocardial energy metabolism: mechanisms revealed through an integration of 18F-FDG PET/CT and data-independent acquisition proteomics

Cardiac metastasis mimicking acute myocardial infarction in a patient with urachal carcinoma: a case report and diagnostic dilemma

Investigation of Sheng Mai Yin in the treatment of anthracycline-induced frequent premature ventricular contractions in cancer patients: study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial

NO/NOS system dysregulation as a key molecular mechanism in chemotherapy-induced cardiotoxicity: a review

Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysis

Case Report: Diagnostic challenges and therapeutic approaches in cardiac intimal sarcoma: a rare clinical case study

Current strategies for prevention of cancer therapy-related cardiotoxicity: pharmacological, non-pharmacological and emerging approaches

Analysis of risk factors for major adverse cardiac events in patients with multiple myeloma

From bench to bedside: investigating SGLT2 inhibitors as a novel strategy against chemotherapy-induced cardiomyopathy

A case report of hepatocarcinoma-originated pericardial malignancy

L-shaped association of low-density lipoprotein cholesterol with all-cause and cardiovascular mortality in cancer survivors: a population-based cohort study

SGLT2i use is associated with reduced risks of cardiopulmonary inflammatory complications in cancer patients with diabetes: a retrospective cohort study

Case Report: Coronary vasospasm precipitating STEMI and polymorphic ventricular tachycardia—a case of cardiotoxicity from 5-FU based chemotherapy in a 41-year-old woman

Pharmacological interventions to prevent cardiotoxicity in patients undergoing anthracycline-based chemotherapy: a network meta-analysis

Case Report: The carney complex led to the tragic passing of a young girl in the prime of her life

MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances

Case Report: Case of cardiac metastases from melanoma, treated by stereotactic radiotherapy, using a MICRA implant